Daniel C Beachler

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Venues

Drug safety

Pharmacoepidemiology and drug safety

Future oncology (London, England)

BMC cancer

HealthCore Inc.

Johns Hopkins School of Public Health (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

HealthCore Inc. May 22 2016

United States

Senior Researcher :: Safety & Epidemiology

National Cancer Institute

United States

Fellow :: Cancer Epidemiology and Genetics

Education History

Johns Hopkins School of Public Health

United States

PHD :: Epidemiology

Publications

Todd R Sponholtz, Aziza Jamal-Allial, Shiva K Vojjala, Anahit Papazian, Biruk Eshete, Mark Paullin, Seyed Hamidreza Mahmoudpour, Patrice Verpillat, Daniel C Beachler
Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018. Pharmacoepidemiology and drug safety 33 (8) (2024)
Stephan Lanes, Daniel C Beachler
Validation to Correct for Outcome Misclassification Bias. Pharmacoepidemiology and drug safety (2023)
Stephan Lanes, Daniel C Beachler
Validation to correct for outcome misclassification bias. Pharmacoepidemiology and drug safety (2023)
Daniel C Beachler, Francois Xavier Lamy, Francesca Kolitsopoulos, Jade Dinh, Anahit Papazian, Aziza Jamal-Allial, Seyed Hamidreza Mahmoudpour, Elisabete Michelon, Patrice Verpillat
Incidence of safety events after immune checkpoint inhibitor initiation for advanced-stage non-small-cell lung cancer: a real-world study. Future oncology (London, England) 18 (26) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)
Daniel C Beachler, Cynthia de Luise, Aziza Jamal-Allial, Ruihua Yin, Devon H Taylor, Ayako Suzuki, James H Lewis, James W Freston, Stephan Lanes
Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study. BMC cancer 21 (1) (2021)
Daniel C Beachler, Devon H Taylor, Mary S Anthony, Ruihua Yin, Ling Li, Catherine W Saltus, Lin Li, Alka Shaunik, Kathleen E Walsh, Kenneth J Rothman, Catherine B Johannes, Vanita R Aroda, Warner Carr, Pinkus Goldberg, Andrew Accardi, John Shane O'Shura, Kristen Sharma, Juhaeri Juhaeri, Stephan Lanes, Chuntao Wu
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data. Pharmacoepidemiology and drug safety 30 (7) (2021)
Daniel C Beachler, Devon H Taylor, Mary S Anthony, Ruihua Yin, Ling Li, Catherine W Saltus, Lin Li, Alka Shaunik, Kathleen E Walsh, Kenneth J Rothman, Catherine B Johannes, Vanita R Aroda, Warner Carr, Pinkus Goldberg, Andrew Accardi, John Shane O'Shura, Kristen Sharma, Juhaeri Juhaeri, Stephan Lanes, Chuntao Wu
Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data". Pharmacoepidemiology and drug safety (2021)
Daniel C Beachler, Francois-Xavier Lamy, Leo Russo, Devon H Taylor, Jade Dinh, Ruihua Yin, Aziza Jamal-Allial, Samuel Dychter, Stephan Lanes, Patrice Verpillat
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer. Journal of ovarian research 13 (1) (2020)
Daniel C Beachler, Gail Fernandes, Gaurav Deshpande, Jamileh Jemison, Jennifer G Lyons, Stephan Lanes, Jinan Liu, Annie McNeill
Patient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a large commercial database. Current medical research and opinion 34 (6) (2018)
Daniel C Beachler, Cynthia de Luise, Ruihua Yin, Kelsey Gangemi, Philip T Cochetti, Stephan Lanes
Predictive model algorithms identifying early and advanced stage ER+/HER2- breast cancer in claims data. Pharmacoepidemiology and drug safety 28 (2) (2018)

Daniel C Beachler.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel C Beachler